Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Radient Technologies Inc. Announces Shares for Services Issuance

Posted on: 24 Jan 18

EDMONTON, Alberta, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Corporation”) (TSX Venture:RTI) announces that the Corporation has issued an aggregate of 28,024 common shares to third party consultants for services provided during the quarter ended December 31, 2017, pursuant to the shares for services agreements previously approved by the TSX Venture Exchange.

The common shares were issued at the TSX Venture Exchange closing share price on December 29, 2017 of $1.76.

About Radient
Radient extracts natural compounds from a range of biological materials using microwave assisted processing ("MAP™"), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its 20,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health and personal care markets. Visit for more information.

Denis Taschuk, Chief Executive Officer,, (780) 465-1318;
Mike Cabigon, Chief Operating Officer,, (780) 465-1318


Last updated on: 24/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.